[1]郭艳风,韩芳毅,周红艳,等.L型氨基酸转运体1和血管内皮生长因子在甲状腺乳头状癌中的表达及意义[J].新乡医学院学报,2017,34(1):036-38.[doi:10.7683/xxyxyxb.2017.01.010]
 GUO Yan-feng,HAN Fang-yi,ZHOU Hong-yan,et al.Expressions of L-type amino acid transporter 1 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinical significance[J].Journal of Xinxiang Medical University,2017,34(1):036-38.[doi:10.7683/xxyxyxb.2017.01.010]
点击复制

L型氨基酸转运体1和血管内皮生长因子在甲状腺乳头状癌中的表达及意义
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年1
页码:
036-38
栏目:
临床研究
出版日期:
2017-01-05

文章信息/Info

Title:
Expressions of L-type amino acid transporter 1 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinical significance
作者:
郭艳风1韩芳毅2周红艳1原志庆3
(1.新乡市第一人民医院病理科,河南 新乡 453000;2.新乡医学院第三附属医院病理科,河南 新乡 453003;3.新乡医学院病理学教研室,河南 新乡 453003)
Author(s):
GUO Yan-feng1HAN Fang-yi2ZHOU Hong-yan1YUAN Zhi-qing3
(1.Department of Pathology,the First People′s Hospital of Xinxiang,Xinxiang 453000,Henan Province,China;2.Department of Pathology,the Third Affiliated Hospital of Xinxiang Medical University,Xinxiang 453003,Henan Province,China;3.Department of Pathology,Xinxiang Medical University,Xinxiang 453003,Henan Province,China)
关键词:
L型氨基酸转运体1血管内皮生长因子甲状腺乳头状癌免疫组织化学
Keywords:
L-type amino acid transporter 1vascular endothelial growth factorpapillary thyroid carcinomaimmunohistochemisy
分类号:
R736.1
DOI:
10.7683/xxyxyxb.2017.01.010
文献标志码:
A
摘要:
目的 探讨L型氨基酸转运体1(LAT1)和血管内皮生长因子(VEGF)在甲状腺乳头状癌(PTC)中的表达及意义。方法 采用免疫组织化学法检测68例PTC和相应癌旁组织中LAT1蛋白及VEGF蛋白的表达,并分析LAT1与PTC临床病理参数的关系及LAT1和VEGF的相关性。结果 LAT1蛋白在PTC组织和相应癌旁组织中的阳性表达率分别为83.8%和8.8%,VEGF蛋白在PTC组织和相应癌旁组织中的阳性表达率分别为88.2%和7.4%,LAT1蛋白和VEGF蛋白在PTC组织中的阳性表达率均高于癌旁组织(P<0.05);LAT1蛋白在PTC组织中的阳性表达与肿瘤临床分期和淋巴结转移相关(P<0.05),与年龄、性别和肿瘤大小无关(P>0.05);PTC组织中LAT1蛋白和VEGF蛋白表达呈正相关(P<0.05)。结论 LAT1可能通过调控VEGF表达而促进PTC的发生与演进,并可能成为PTC治疗的一个新的分子靶点。
Abstract:
Objective To explore the expression of L-type amino acid transporter 1(LAT1)and vascular endothelial growth factor(VEGF) in papillary thyroid carcinoma(PTC) and their clinical significance.Methods The expression of LAT1 and VEGF in 68 cases of PTC and para-carcinoma tissue were detected by immunohistochemisy.The relationship between the expression of LAT1 protein and clincopathological parameters of PTC were analyzed;the correlation between the expression of LAT1 protein and VEGF protein were analyzed.Results The positive expression rate of LAT1 protein in PTC and para-carcinoma tissue was 83.8% and 8.8% respectively;the positive expression rate of VEGF protein in PTC and para-carcinoma tissue was 88.2% and 7.4 % respectively;the positive expression rate of LAT1 and VEGF protein in PTC tissue was significantly higher than that in para-carcinoma tissue(P<0.05).The expression of LAT1 protein was related to lymph node metastasis and clinical stage of tumor(P<0.05),while the expression of LAT1 protein was not related to age,sex and tumor size(P>0.05).There was positive correlation between the expression of LAT1 protein and VEGF protein in PTC(P<0.05).Conclusion LAT1 may promote the occurrence and progression of PTC by regulating the expression of VEGF,which may provide a new therapeutic target for the treatment of PTC.

参考文献/References:

[1] IMAI H,KAIRA K,ORIUCHI N,et al.Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer[J].Anticancer Res,2010,30(12):4819-4828.
[2] KAIRA K,ORIUCHI N,TAKAHASHI T,et al.L-type amino acid transporter 1(LAT1) expression in malignant pleural mesothelioma[J].Anticancer Res,2011,31(12):4075-4082.
[3] LI J,QIANG J,CHEN S F,et al.The impact of L-type amino acid transporter 1(LAT1) in human hepatocellular carcinoma[J].Tumour Biol,2013,34(5):2977-2981.
[4] SAKATA T,FERDOUS G,TSURUTA T,et al.L-type amino acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer[J].Pathol Int,2009,59(1):7-18.
[5] 许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231.
[6] ICHINOE M,MIKAMI T,YOSHIDA T,et al.High expression of L-type amino acid transporter 1(LAT1) in gastric carcinomas:comparison with non-cancerous lesions[J].Pathol Int,2011,61:281-289.
[7] HAINING Z,KAWAI N,MIYAKE K,et al.Relation of LAT1/4F2hc expression with pathological grade,proliferation and angiogenesis in human gliomas[J].BMC Clin Pathol,2012,12:4.
[8] 石婷娟.结肠癌中LAT1、CD98及KI-67的表达及其临床意义[D].太原:山西医科大学,2014.
[9] WATANABE J,YOKOYAMA Y,FUTAGAMI M,et al.L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression[J].Int J Gynecol Cancer,2014,24(4):659-663.
[10] KAIRA K,ORIUCHI N,IMAI H,et al.L-type amino acid transporter 1(LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas[J].J Surg Oncol,2009,99(7):433-438.
[11] KAIRA K,ORIUCHI N,IMAI H,et al.L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms[J].Cancer Sci,2008,99(12):2380-2386.
[12] XU M,SAKAMOTO S,MATASUSHIMA J,et al.Up-regulation of LAT1 during antiandrogen therapy contributes to progression in prostate cancer cells[J].J Urol,2016,195(5):1588-1597.
[13] 袁牧之,林颖,刘泉.视网膜静脉阻塞患者血浆和泪液中血管内皮生长因子表达的研究[J].眼科新进展,2016,36(5):468-470.
[14] 曹明芳,江蕊,张文贤,等.脉络膜新生血管模型大鼠视网膜核转录因子-κB p65、血管内皮生长因子和硫性成纤维细胞生长因子表达的变化[J].眼科新进展,2016,36(7):615-617,625.
[15] 唐清,汤继宏.血管内皮生长因子对癫NFDF4发作的神经保护作用[J].中华实用儿科临床杂志,2015,30(12):958-960.
[16] KAIRA K,ORIUCHI N,SHIMIZU K,et al.Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer[J].Cancer Sci,2009,100(4):753-758.
[17] KAIRA K,SUNOSE Y,OHSHIMA Y,et al.Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer[J].BMC Cancer,2013,13:482.

相似文献/References:

[1]李 娜,李继煜,张景航,等.食管鳞癌中CD44H、P - 选择素和血管内皮生长因子的表达与淋巴结转移的关系[J].新乡医学院学报,2006,23(05):467.
[2]冯书营,李三强,刘小转,等.血管内皮生长因子在四氯化碳诱导的急性肝损伤小鼠肝组织中的表达[J].新乡医学院学报,2011,28(03):268.
[3]张 慧,张 婷,宋 宇,等.薏苡仁对实验性腹腔粘连大鼠腹腔液炎性相关因子及粘连组织血管内皮生长因子、血管内皮标志物CD34表达的影响[J].新乡医学院学报,2014,31(10):792.[doi:10.7683/xxyxyxb.2014.10.006]
[4]陈广理1,龚树生2,陈 沛3,等.血管内皮生长因子及其双受体系统在鼻咽癌中的表达[J].新乡医学院学报,2014,31(12):974.[doi:10.7683/xxyxyxb.2014.12.003]
[5]刘月君.基质金属蛋白酶9、基质金属蛋白酶组织抑制剂1和血管内皮生长因子在视网膜母细胞瘤组织中的表达[J].新乡医学院学报,2014,31(12):1015.[doi:10.7683/xxyxyxb.2014.12.014]
[6]曾松柏,张 梅,董化江,等.姜黄素对急性心肌梗死大鼠血管内皮生长因子及肿瘤坏死因子-α的影响[J].新乡医学院学报,2016,33(10):852.[doi:10.7683/xxyxyxb.2016.10.004]
 ZENG Song-bai,ZHANG Mei,DONG Hua-jiang,et al.Effect of curcumin on vascular endothelial growth factor and tumor necrosis factor-α in rats with acute myocardial infarction[J].Journal of Xinxiang Medical University,2016,33(1):852.[doi:10.7683/xxyxyxb.2016.10.004]
[7]于 建,张景航,杨晓煜,等.真核细胞翻译起始因子-4E在食管癌变过程中的表达变化及意义[J].新乡医学院学报,2017,34(12):1073.[doi:10.7683/xxyxyxb.2017.12.007]
 YU Jian,ZHANG Jing-hang,YANG Xiao-yu,et al.Expression changes and significance of eukaryocyte initiation factors-4E in esophageal carcinogenesis[J].Journal of Xinxiang Medical University,2017,34(1):1073.[doi:10.7683/xxyxyxb.2017.12.007]
[8]李 琦.丁苯酞软胶囊联合清脑益智方治疗血管性痴呆疗效观察[J].新乡医学院学报,2019,36(7):677.[doi:10.7683/xxyxyxb.2019.07.019]
 LI Qi.Effect of butylphthalide soft capsule combined with Qingnao Yizhi Decoction in the treatment of vascular dementia[J].Journal of Xinxiang Medical University,2019,36(1):677.[doi:10.7683/xxyxyxb.2019.07.019]
[9]南 燕,侯妍妍,李玉洁.不同剂量米非司酮对子宫内膜异位症大鼠异位内膜组织中环氧合酶-2和血管内皮生长因子表达的影响[J].新乡医学院学报,2019,36(6):521.[doi:10.7683/xxyxyxb.2019.06.005]
 NAN Yan,HOU Yan-yan,LI Yu-jie.Effect of different doses of mifepristone on the expression of cyclooxygenase-2 and vascular endothelial growth factor in endometriosis rats[J].Journal of Xinxiang Medical University,2019,36(1):521.[doi:10.7683/xxyxyxb.2019.06.005]
[10]杨琳红,王维峰,魏晓丽,等.核转录因子-κB信号途径对鼻息肉细胞中缺氧诱导因子-1α和血管内皮生长因子表达的影响[J].新乡医学院学报,2017,34(11):960.[doi:10.7683/xxyxyxb.2017.11.002]
 YANG Lin-hong,WANG Wei-feng,WEI Xiao-li,et al.Effect of nuclear factor-κB signaling pathway on the expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in nasal polyp cells[J].Journal of Xinxiang Medical University,2017,34(1):960.[doi:10.7683/xxyxyxb.2017.11.002]

更新日期/Last Update: 2017-01-05